S&P 500
(0.25%) 5 321.41 points
Dow Jones
(0.17%) 39 873 points
Nasdaq
(0.22%) 16 833 points
Oil
(-0.25%) $79.06
Gas
(-1.50%) $2.63
Gold
(0.13%) $2 429.10
Silver
(1.00%) $32.40
Platinum
(0.64%) $1 067.70
USD/EUR
(-0.02%) $0.921
USD/NOK
(-0.06%) $10.65
USD/GBP
(-0.06%) $0.786
USD/RUB
(0.30%) $90.49

Realtime updates for Luminex Corporation [LMNX]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies
Last Updated31 Dec 1970 @ 19:00

0.00% $ 36.99

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide...

Stats
Today's Volume 1.02M
Average Volume 650 237
Market Cap 0.00
EPS $0 ( 2021-08-02 )
Last Dividend $0.100 ( 2021-06-16 )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0.188 (0.51%)
Insider Trading
Date Person Action Amount type
2021-07-14 Ogunro Edward A Sell 10 760 Common Stock
2021-07-14 Ogunro Edward A Sell 50 133 Common Stock
2021-07-14 Mcnamara Kevin M Sell 24 443 Common Stock
2021-07-14 Mcnamara Kevin M Sell 75 925 Common Stock
2021-07-14 Erickson Thomas W Sell 79 204 Common Stock
INSIDER POWER
0.00
Last 100 transactions
Buy: 1 457 367 | Sell: 3 933 642

Volume Correlation

Long: 0.06 (neutral)
Short: 0.88 (strong)
Signal:(63.839) Same movement expected

Luminex Corporation Correlation

10 Most Positive Correlations
DSPG0.935
STAY0.893
MSON0.868
PPD0.857
DVCR0.838
CHMA0.834
MDCA0.827
MXIM0.813
GAINM0.811
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Luminex Corporation Correlation - Currency/Commodity

The country flag -0.03
( neutral )
The country flag -0.01
( neutral )
The country flag -0.69
( moderate negative )
The country flag 0.17
( neutral )
The country flag 0.38
( neutral )
The country flag -0.48
( neutral )

Luminex Corporation Financials

Annual 2020
Revenue: $417.40M
Gross Profit: $247.85M (59.38 %)
EPS: $0.336
FY 2020
Revenue: $417.40M
Gross Profit: $247.85M (59.38 %)
EPS: $0.336
FY 2019
Revenue: $334.64M
Gross Profit: $182.74M (54.61 %)
EPS: $-0.0900
FY 2018
Revenue: $315.82M
Gross Profit: $195.49M (61.90 %)
EPS: $0.420

Financial Reports:

No articles found.

Luminex Corporation Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Luminex Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.83 - Potential for dividend initiation, but uncertain (16.55%)
Information
First Dividend $0.0600 2017-03-22
Last Dividend $0.100 2021-06-16
Next Dividend $0 N/A
Payout Date 2021-07-08
Next Payout Date N/A
# dividends 18 --
Total Paid Out $1.350 --
Avg. Dividend % Per Year 0.22% --
Score 4.61 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.83
Div. Directional Score 9.48 --
Next Divdend (Est)
(2024-06-27)
$0 Estimate 0.00 %
Dividend Stability
0.14 Bad
Dividend Score
4.61
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2017 $0.240 1.18%
2018 $0.240 1.18%
2019 $0.300 1.32%
2020 $0.370 1.61%
2021 $0.200 0.82%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
OXLC Dividend Diamond 2023-12-14 Monthly 14 10.00% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
OXSQ Dividend Royal 2023-12-14 Monthly 21 9.10% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
HRZN Dividend Royal 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.03631.5009.2710.00[0 - 0.5]
returnOnAssetsTTM0.01971.2009.3410.00[0 - 0.3]
returnOnEquityTTM0.03091.500-0.768-1.152[0.1 - 1]
payoutRatioTTM1.087-1.00010.00-10.00[0 - 1]
currentRatioTTM5.820.80010.008.00[1 - 3]
quickRatioTTM4.300.80010.008.00[0.8 - 2.5]
cashRatioTTM3.541.50010.0010.00[0.2 - 2]
debtRatioTTM0.271-1.5005.48-8.21[0 - 0.6]
interestCoverageTTM3.561.0009.799.79[3 - 30]
operatingCashFlowPerShareTTM1.0902.009.6410.00[0 - 30]
freeCashFlowPerShareTTM0.6992.009.6510.00[0 - 20]
debtEquityRatioTTM0.404-1.5008.38-10.00[0 - 2.5]
grossProfitMarginTTM0.5941.0003.443.44[0.2 - 0.8]
operatingProfitMarginTTM0.1021.0009.979.97[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2391.0009.789.78[0.2 - 2]
assetTurnoverTTM0.5420.8009.727.78[0.5 - 2]
Total Score13.13

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM111.731.00010.000[1 - 100]
returnOnEquityTTM0.03092.50-0.494-1.152[0.1 - 1.5]
freeCashFlowPerShareTTM0.6992.009.7710.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM1.0902.009.6410.00[0 - 30]
payoutRatioTTM1.0871.50010.00-10.00[0 - 1]
pegRatioTTM0.5521.5009.650[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1201.0009.510[0.1 - 0.5]
Total Score5.83

Luminex Corporation Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Luminex Corporation

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators